Stay updated on APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and older items (a funding notice and v3.4.1) were removed. These are administrative updates to the page’s revision history rather than to study data or core content.
    Difference
    0.5%
    Check dated 2026-02-11T14:15:21.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page adds a government funding notice banner and updates the revision from v3.4.0 to v3.4.1, which affects only site-wide notices and versioning rather than core trial data; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:21:49.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The history page now includes a glossary, color-coded change highlights (green for additions, red for deletions), and a visible revision label (v3.4.0). This is a UI/readability improvement that does not affect core study data.
    Difference
    0.6%
    Check dated 2026-01-28T05:53:11.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The screenshot shows a minor version update from Revision: v3.3.3 to v3.3.4 in the Record History; no substantive changes to trial data or page content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:29:08.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added a new revision entry: Revision: v3.3.3 to the history. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the history.
    Difference
    0.1%
    Check dated 2025-12-23T22:09:05.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    The history adds a Terminated status and indicates Results Posted with new Outcome Measures (Results). A new Revision: v3.3.2 entry dated 2025-11-21 is recorded.
    Difference
    0.6%
    Check dated 2025-11-25T13:55:46.000Z thumbnail image

Stay in the know with updates to APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.